Colorado Therapeutics

About:

Advancements in crosslinking technology for soft tissue repair

Website: http://www.co-therapeutics.com/

Description:

Colorado Therapeutics, LLC, (“Company”) a privately held company, is focused on developing xenogenic (sourced from different mammalian species) biologic tissue matrix products for a broad range of soft tissue reinforcement, regenerative, and vascular applications. The Company is leveraging over 15 years of innovative and proprietary tissue processing technology to produce a superior biologic product that combines the benefits of currently available biologic and synthetic products.

Total Funding Amount:

$6.87M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Louisville, Colorado, United States

Founded Date:

2015-01-01

Contact Email:

info(AT)CO-Therapeutics.com

Founders:

Joseph Horn

Number of Employees:

11-50

Last Funding Date:

2017-04-17

IPO Status:

Private

Industries:

© 2025 bioDAO.ai